Analysts Viewpoint Analysts optimistic about VYGR’s future growth prospects Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Voyager Therapeutics
Analysts Viewpoint Cantor Fitzgerald analysts initates an Overweight rating for Voyager Therapeutics Inc (VYGR) Voyager Therapeutics Inc’s filing revealed that its Chief Medical Officer Ferguson Toby unloaded Company’s shares for reported $34595.0 on Apr
Analysts Viewpoint An Analysis of Voyager Therapeutics Inc (VYGR)’s Potential Price Growth In a filing, Voyager Therapeutics Inc revealed its Chief Medical Officer Ferguson Toby unloaded Company’s shares for reported $34595.0 on
News Voyager Therapeutics, Inc. (VYGR) Experienced a Striking Upswing On January 3, 2024, during the pre-market hours, Voyager Therapeutics, Inc. (VYGR) experienced a noteworthy upswing that grabbed the attention